Li, Y., Chu, Y., Shi, G., Wang, X., Ye, W., Shan, C., . . . Wu, H. (2022). A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer. Acta Pharmaceutica Sinica B, 12(11), 4165. https://doi.org/10.1016/j.apsb.2022.05.003
Chicago-referens (17:e uppl.)Li, Yan, et al. "A Novel Inhibitor of ARfl and ARv7 Induces Protein Degradation to Overcome Enzalutamide Resistance in Advanced Prostate Cancer." Acta Pharmaceutica Sinica B 12, no. 11 (2022): 4165. https://doi.org/10.1016/j.apsb.2022.05.003.
MLA-referens (9:e uppl.)Li, Yan, et al. "A Novel Inhibitor of ARfl and ARv7 Induces Protein Degradation to Overcome Enzalutamide Resistance in Advanced Prostate Cancer." Acta Pharmaceutica Sinica B, vol. 12, no. 11, 2022, p. 4165, https://doi.org/10.1016/j.apsb.2022.05.003.
